BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 34707513)

  • 1. Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets.
    Reina-Couto M; Pereira-Terra P; Quelhas-Santos J; Silva-Pereira C; Albino-Teixeira A; Sousa T
    Front Physiol; 2021; 12():746494. PubMed ID: 34707513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.
    Borow KM; Yaroshinsky A; Greenberg B; Perin EC
    Circ Res; 2019 Jul; 125(3):265-281. PubMed ID: 31318648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelitis profile in acute heart failure and cardiogenic shock patients: Endocan as a potential novel biomarker and putative therapeutic target.
    Reina-Couto M; Silva-Pereira C; Pereira-Terra P; Quelhas-Santos J; Bessa J; Serrão P; Afonso J; Martins S; Dias CC; Morato M; Guimarães JT; Roncon-Albuquerque R; Paiva JA; Albino-Teixeira A; Sousa T
    Front Physiol; 2022; 13():965611. PubMed ID: 36035482
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empagliflozin: A Review in Symptomatic Chronic Heart Failure.
    Frampton JE
    Drugs; 2022 Nov; 82(16):1591-1602. PubMed ID: 36374374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Central Role for Monocyte-Platelet Interactions in Heart Failure.
    Glezeva N; Gilmer JF; Watson CJ; Ledwidge M
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):245-61. PubMed ID: 26519384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock.
    Hernandez-Montfort J; Kanwar M; Sinha SS; Garan AR; Blumer V; Kataria R; Whitehead EH; Yin M; Li B; Zhang Y; Thayer KL; Baca P; Dieng F; Harwani NM; Guglin M; Abraham J; Hickey G; Nathan S; Wencker D; Hall S; Schwartzman A; Khalife W; Li S; Mahr C; Kim J; Vorovich E; Pahuja M; Burkhoff D; Kapur NK
    JACC Heart Fail; 2023 Feb; 11(2):176-187. PubMed ID: 36342421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular outcomes and trends of Transcatheter vs. Surgical aortic valve replacement among octogenarians with heart failure: A Propensity Matched national cohort analysis.
    Sattar Y; Song D; Almas T; Zghouzi M; Talib U; Suleiman AM; Ahmad B; Arshad J; Ullah W; Zia Khan M; Bianco CM; Bagur R; Rashid M; Mamas MA; Alraies MC
    Int J Cardiol Heart Vasc; 2022 Oct; 42():101119. PubMed ID: 36161232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Key Inflammatory Mechanisms Underlying Heart Failure: A Comprehensive Review.
    Papamichail A; Kourek C; Briasoulis A; Xanthopoulos A; Tsougos E; Farmakis D; Paraskevaidis I
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and chronic heart failure: from biomarkers to novel anti-inflammatory therapeutic strategies.
    Bouras G; Giannopoulos G; Hatzis G; Alexopoulos D; Leventopoulos G; Deftereos S
    Med Chem; 2014; 10(7):682-99. PubMed ID: 25102199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-Inflammatory Derangement of the Immuno-Interactome in Heart Failure.
    Kumar P; Lim A; Poh SL; Hazirah SN; Chua CJH; Sutamam NB; Arkachaisri T; Yeo JG; Kofidis T; Sorokin V; Lam CSP; Richards AM; Albani S
    Front Immunol; 2022; 13():817514. PubMed ID: 35371099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential mechanisms of benefit with thalidomide in chronic heart failure.
    Aukrust P; Yndestad A; Damås JK; Ueland T; Øie E; Gullestad L
    Am J Cardiovasc Drugs; 2007; 7(2):127-34. PubMed ID: 17503883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome differences in acute vs. acute on chronic heart failure and cardiogenic shock.
    Jones TL; Tan MC; Nguyen V; Kearney KE; Maynard CC; Anderson E; Mahr C; McCabe JM
    ESC Heart Fail; 2020 Jun; 7(3):1118-1124. PubMed ID: 32160418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the Novel Inflammatory Marker GlycA and Incident Heart Failure and Its Subtypes of Preserved and Reduced Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis.
    Jang S; Ogunmoroti O; Ndumele CE; Zhao D; Rao VN; Fashanu OE; Tibuakuu M; Otvos JD; Benson EM; Ouyang P; Michos ED
    Circ Heart Fail; 2020 Aug; 13(8):e007067. PubMed ID: 32762458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.
    Tromp J; Westenbrink BD; Ouwerkerk W; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Lang CC; Ng LL; Zannad F; Zwinderman AH; Hillege HL; van der Meer P; Voors AA
    J Am Coll Cardiol; 2018 Sep; 72(10):1081-1090. PubMed ID: 30165978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from a pre-specified meta-analysis of sodium-glucose cotransporter-2 (SGLT2) inhibitors in heart failure: Time for new clinical recommendations.
    Kotit S
    Glob Cardiol Sci Pract; 2023 May; 2023(2):e202314. PubMed ID: 37351098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Markers and Risk of Heart Failure With Reduced to Preserved Ejection Fraction.
    Albar Z; Albakri M; Hajjari J; Karnib M; Janus SE; Al-Kindi SG
    Am J Cardiol; 2022 Mar; 167():68-75. PubMed ID: 34986991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal Muscle Function, Structure, and Metabolism in Patients With Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction.
    Bekfani T; Bekhite Elsaied M; Derlien S; Nisser J; Westermann M; Nietzsche S; Hamadanchi A; Fröb E; Westphal J; Haase D; Kretzschmar T; Schlattmann P; Smolenski UC; Lichtenauer M; Wernly B; Jirak P; Lehmann G; Möbius-Winkler S; Schulze PC
    Circ Heart Fail; 2020 Dec; 13(12):e007198. PubMed ID: 33302709
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.